Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure
Author:
Affiliation:
1. Department of Cardiology; University of Hull, Castle Hill Hospital; Cottingham Kingston-upon-Hull HU16 5JQ UK
2. Department of Primary Care and General Practice; University of Birmingham; Edgbaston Birmingham B15 2TT UK
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Reference37 articles.
1. Is aspirin ‘The Weakest Link’ in cardiovascular prophylaxis. The surprising lack of evidence supporting the use of aspirin for cardiovascular disease;Cleland;Prog Cardiovasc Dis,2002
2. Is aspirin safe for patients with heart failure=;Cleland;Br Heart J,1995
3. The warfarin/aspirin study in heart failure (WASH): a randomised trial comparing anti-thrombotic strategies for patients with heart failure;Cleland;Am Heart J,2004
4. The WASH study (warfarin/aspirin study in heart failure): rationale, design and methods;The WASH study steering committee and investigators;Eur J Heart Fail,1999
5. The warfarin and antiplatelet therapy in heart failure trial (WATCH): rationale, design and baseline patient characteristics;Massie;J Card Fail,2004
Cited by 207 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Case Report: COVID-19 with cytokine storm in a 16-year-old patient: if heart failures comes think about levosimendan;F1000Research;2023-02-07
2. Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks;Frontiers in Pharmacology;2022-05-10
3. In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography;Journal of Medicinal Chemistry;2021-04-27
4. Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials;Children;2021-04-22
5. Case Report: COVID-19 with cytokine storm in a 16-year-old patient: if heart failures comes think about levosimendan;F1000Research;2021-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3